Effective correction of haemostatic disorders in patients with combat-related injuries of large joints should therefore include targeted management of fibrinolytic dysfunction, especially in individuals with concurrent chronic liver or kidney diseases, which are associated with reduced circulating plasminogen levels. The gene discussed is PLG; the disease is kidney disorder.